Ustar Biotechnologies (Hangzhou)
Latest round
- Series E
Last raised
- Nov 2021
Total raised
- $47M
Investors
- 4
About Ustar Biotechnologies (Hangzhou)
Based in Hangzhou, China and established in 2005, Ustar Biotechnologies (Hangzhou) Ltd is a biotechnology company that engaged in research and development of point of caretesting(POCT) technology and products. The company's technology has received support from the Bill & Melinda Gates Foundation, the World Health Organization (WHO) and other organizations. The company focuses on POCT molecular diagnostic products and related technology such as constant temperature amplification technology and reagent vitrification technology. The company's products have covered more than 2,000 medical and health institutions in China and sold to about 60 countries.
Who invested in Ustar Biotechnologies (Hangzhou)
4 investors across 3 rounds
See all investors in Ustar Biotechnologies (Hangzhou)
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ustar Biotechnologies (Hangzhou)
Who invested in Ustar Biotechnologies (Hangzhou)?
Ustar Biotechnologies (Hangzhou) has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ustar Biotechnologies (Hangzhou) raised?
Ustar Biotechnologies (Hangzhou) has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Ustar Biotechnologies (Hangzhou) last raise money?
Ustar Biotechnologies (Hangzhou)'s most recent round on record is a Series E, in Nov 2021.
What does Ustar Biotechnologies (Hangzhou) do?
Based in Hangzhou, China and established in 2005, Ustar Biotechnologies (Hangzhou) Ltd is a biotechnology company that engaged in research and development of point of caretesting(POCT) technology and products.
Where is Ustar Biotechnologies (Hangzhou) headquartered?
Ustar Biotechnologies (Hangzhou) is headquartered in Hangzhou, China.
Which VCs invest in companies like Ustar Biotechnologies (Hangzhou)?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Ustar Biotechnologies (Hangzhou)'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like Ustar Biotechnologies (Hangzhou)? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.